In non-small cell lung cancer (NSCLC), piR-651 upregulation correlates with a significant increase in tumor growth and metastasis, affecting cell cycle arrest and inducing cyclin D1 and CDK4 and suggesting piR-651 as a potential oncogene. Here, CCND1 is linked to non-small cell lung carcinoma.